|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: GLOBOCAN 2008 v1.2, Cancer Incidence and
Mortality. Worldwide: IARC CancerBase No. 10. Lyon, France.
http://globocan.iarc.fr.
|
|
2
|
Caron M, Choquet-Kastylevsky G and
Joubert-Caron R: Cancer immunomics using autoantibody signatures
for biomarker discovery. Mol Cell Proteomics. 6:1115–1122. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Desmetz C, Cortijo C, Mange A and Solassol
J: Humoral response to cancer as a tool for biomarker discovery.
Proteomics. 72:982–988. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang JY, Megliorino R, Peng XX, Tan EM,
Chen Y and Chan EKL: Antibody detection using tumor-associated
antigen mini-array in immunodiagnosing human hepatocellular
carcinoma. Hepatology. 46:107–114. 2007. View Article : Google Scholar
|
|
5
|
Tan EM and Zhang JY: Autoantibodies to
tumor-associated antigens: reporters from the immune system.
Immunol Rev. 222:328–340. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu HL, Goodell V and Disis ML: Humoral
immunity directed against tumor-associated antigens as potential
biomarkers for the early diagnosis of cancer. J Proteome Res.
7:1388–1394. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Disis ML, Pupa SM, Gralow JR, Dittadi R,
Menard S and Cheever MA: High-titer HER-2/neu protein-specific
antibody can be detected in patients with early-stage breast
cancer. J Clin Oncol. 15:3363–3367. 1997.PubMed/NCBI
|
|
8
|
Shimbo T, Tanemura T, Yamazaki T, Tamai K,
Katayama I and Kaneda Y: Serum anti-BPAG1 auto-antibody is a novel
marker for human melanoma. PLoS One. 5:e10566–e10573. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Defresne F, Bouzin C, Guilbaud C, et al:
Differential influence of anticancer treatments and angiogenesis on
the seric titer of autoantibody used as tumor and metastasis
biomarker. Neoplasia. 12:562–570. 2010.PubMed/NCBI
|
|
10
|
Su ZZ, Kang DC, Chen Y, et al:
Identification and cloning of human astrocyte genes displaying
elevated expression after infection with HIV-1 or exposure to HIV-1
envelope glycoprotein by rapid subtraction hybridization. Oncogene.
21:3592–3602. 2002. View Article : Google Scholar
|
|
11
|
Kang DC, Su ZZ, Sarkar D, et al: Cloning
and characterization of HIV-1-inducible astrocyte elevated gene-1,
AEG-1. Gene. 353:8–15. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoo BK, Emdad L, Su ZZ, et al: Astrocyte
elevated gene-1 regulates hepatocellular carcinoma development and
progression. J Clin Invest. 119:465–477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu GH, Chong RA, Yang QF, et al: MTDH
activation by 8q22 genomic gain promotes chemoresistance and
metastasis of poor-prognosis breast cancer. Cancer Cell. 15:9–20.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kikuno N, Shiina H, Urakami S, et al:
Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer
progression through upregulation of FOXO3a activity. Oncogene.
26:7647–7655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu CP, Chen K, Zheng HQ, et al:
Overexpression of astrocyte elevated gene-1 (AEG-1) is associated
with esophageal squamous cell carcinoma (ESCC) progression and
pathogenesis. Carcinogenesis. 30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee SG, Jeon HY, Su ZZ, et al: Astrocyte
elevated gene-1 contributes to the pathogenesis of neuroblastoma.
Oncogene. 28:2476–2484. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Emdad L, Sarkar D, Su ZZ, et al: Astrocyte
elevated gene-1: recent insights into a novel gene involved in
tumor progression, metastasis and neurodegeneration. Pharmacol
Therapeut. 114:155–170. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lawrence N and Chin KL: The metastasis
problem gets stickier. Cancer Cell. 15:1–2. 2009. View Article : Google Scholar
|
|
19
|
Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ
and Fisher PB: Molecular basis of nuclear factor-κB activation by
astrocyte elevated gene-1. Cancer Res. 68:1478–1484. 2008.
|
|
20
|
Emdad L, Sarkar D, Su ZZ, et al:
Activation of the nuclear factor κB pathway by astrocyte elevated
gene-1: implications for tumor progression and metastasis. Cancer
Res. 66:1509–1516. 2006.
|
|
21
|
Emdad L, Lee SG, Su ZZ, et al: Astrocyte
elevated gene-1 (AEG-1) functions as an oncogene and regulates
angiogenesis. Proc Natl Acad Sci USA. 15:21300–21305. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khuda II, Koide N, Noman ASM, et al:
Astrocyte elevated gene-1 (AEG-1) is induced by lipopolysaccharide
as toll-like receptor 4 (TLR4) ligand and regulates TLR4 signaling.
Immunol. 128:e700–e706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brown DM and Ruoslahti E: Metadherin, a
cell surface protein in breast tumors that mediates lung
metastasis. Cancer Cell. 5:365–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dong J, Zeng BH, Xu LH, et al: Anti-CDC25B
auto antibody predicts poor prognosis in patients with advanced
esophageal squamous cell carcinoma. J Transl Med. 8:81–88. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Soussi T: p53 antibodies in the sera of
patients with various types of cancer. Cancer Res. 60:1777–1788.
2000.PubMed/NCBI
|
|
26
|
Crawford LV, Pim DC and Bulbrook RD:
Detection of antibodies against the cellular protein p53 in sera
from patients with breast cancer. Int J Cancer. 30:403–408. 1982.
View Article : Google Scholar : PubMed/NCBI
|
